These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24759319)

  • 1. Opioids and cancer recurrence.
    Juneja R
    Curr Opin Support Palliat Care; 2014 Jun; 8(2):91-101. PubMed ID: 24759319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine and tumor growth and metastasis.
    Afsharimani B; Cabot P; Parat MO
    Cancer Metastasis Rev; 2011 Jun; 30(2):225-38. PubMed ID: 21267766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does regional anaesthesia and analgesia or opioid analgesia influence recurrence after primary cancer surgery? An update of available evidence.
    Ash SA; Buggy DJ
    Best Pract Res Clin Anaesthesiol; 2013 Dec; 27(4):441-56. PubMed ID: 24267550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and tumour metastasis: does the choice of the anesthetic-analgesic technique influence outcome after cancer surgery?
    Connolly C; Buggy DJ
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):468-74. PubMed ID: 27214644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of analgesics in cancer propagation.
    Meserve JR; Kaye AD; Prabhakar A; Urman RD
    Best Pract Res Clin Anaesthesiol; 2014 Jun; 28(2):139-51. PubMed ID: 24993435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial.
    Sessler DI; Ben-Eliyahu S; Mascha EJ; Parat MO; Buggy DJ
    Contemp Clin Trials; 2008 Jul; 29(4):517-26. PubMed ID: 18291727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiophobia in Cancer Biology- Justified? - The Role of Perioperative Use of Opioids in Cancer Recurrence.
    Sekandarzad MW; Doornebal C; Hollmann MW
    Curr Pharm Des; 2019; 25(28):3020-3027. PubMed ID: 31269880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids and breast cancer recurrence.
    Cronin-Fenton D
    Curr Opin Support Palliat Care; 2019 Jun; 13(2):88-93. PubMed ID: 30925533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
    Wang D; Chen T; Zhou X; Couture R; Hong Y
    Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of perioperative opioids on cancer recurrence: a hypothesis.
    Singleton PA; Moss J
    Future Oncol; 2010 Aug; 6(8):1237-42. PubMed ID: 20799870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine.
    Gilbert AK; Hosztafi S; Mahurter L; Pasternak GW
    Eur J Pharmacol; 2004 May; 492(2-3):123-30. PubMed ID: 15178355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid and adjuvant analgesics: compared and contrasted.
    Khan MI; Walsh D; Brito-Dellan N
    Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids.
    Mercadante S; Porzio G; Aielli F; Adile C; Verna L; Ficorella C; Giarratano A; Casuccio A
    Curr Med Res Opin; 2013 Jun; 29(6):661-6. PubMed ID: 23540512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and cancer: friend or foe?
    Wigmore T; Farquhar-Smith P
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):109-18. PubMed ID: 26990052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain.
    Mercadante S; Salvaggio L; Dardanoni G; Agnello A; Garofalo S
    J Pain Symptom Manage; 1998 Feb; 15(2):76-81. PubMed ID: 9494305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.